121 Y Combinator companies in Consumer Health and Wellness, with team size, growth, open roles and funding.
Updated weekly, last on November 9, 2026. Roster from Y Combinator's public directory.
| Company | Batch | Team | 6 mo | 12 mo | Open roles | Total raised | Last round |
|---|---|---|---|---|---|---|---|
Medication & support to beat opioid addiction from home | W20 | 388 | +3% | +11% | YC | $67.7M | Series B$50M, Dec 2021 |
Modern primary care via video and in-person | S15 | 337 | −4% | 4 | $12.5M | Equity crowdfunding$3.5M, Mar 2019 | |
Enabling better self care with at-home hormone tracking. | W19 | 264 | +6% | +10% | YC | $57.5M | Series B$29M, Dec 2025 |
Live home fitness training powered by computer vision. | W15 | 218 | +3% | +3% | YC | $299M | Series C$220M, Apr 2021 |
India's Telemedicine Platform & Online Pharmacy for Dermatology Care | S22 | 162 | +5% | +22% | YC | $3.2M | Seed$2.6M, Sep 2023 |
On-demand prescription delivery. | W15 | 158 | −7% | −11% | 0 | $74.9M | Undisclosed round$14.7M, Jun 2022 |
Online therapy platform for the Spanish-speaking market | W21 | 146 | +4% | +1% | 0 | SeedSep 2022 | |
Making low cost versions of high cost generic drugs. | S18 | 144 | +7% | +19% | 12 | SeedJan 2018 | |
An online provider for greater mental health | S18 | 143 | +1% | +6% | YC | $53.3M | Grant$2M, May 2022 |
Empowering Autism Care Providers to Go Independent | W23 | 131 | +2% | +6% | 83 | $3.3M | Series A$3.2M, Mar 2024 |
A digital well-being program to help people prevent or manage chronic… | W20Inactive | 117 | −4% | −21% | 0 | $12.8M | Series B$6.2M, Jan 2023 |
Precision medicine for Africans and the global population | W19Inactive | 112 | +1% | 0 | $94.7M | Convertible note$50M, Oct 2022 | |
Medicine or testing kit, prescribed online and delivered to your door. | W16Acquired | 111 | −3% | −15% | 0 | $116M | Series C$22.5M, Aug 2020 |
Making private healthcare in India accessible and affordable | W22 | 110 | +2% | +18% | 1 | $12.9M | Undisclosed round$4.3M, Apr 2025 |
Canada's digital health clinic for men | W21 | 99 | +2% | +5% | 8 | $38.9M | Series A$34.7M, Mar 2025 |
App to help people quit or cut back on alcohol use | S21 | 83 | +1% | +2% | YC | $27.4M | Undisclosed round$10M, Apr 2022 |
At-Home health monitoring with silicon photonic chips for data centers | S20 | 81 | +11% | +31% | 1 | $32.8M | Series A$17M, Mar 2025 |
API for at-home health data | W20 | 74 | +37% | +72% | 5 | $18.6M | Series A$18M, Mar 2025 |
ZBiotics makes genetically engineered probiotics. | W18 | 71 | +16% | +25% | 6 | $17.2M | Secondary$12M, Mar 2025 |
Noom for Southeast Asia | S21 | 68 | +6% | +6% | 0 | $2.7M | Non-equity support$2.6M, Feb 2024 |
1:1 ADHD coaching, 5-10X More affordable than alternatives | S21 | 57 | −5% | YC | $3.6M | Seed$25K, Sep 2024 | |
Telehealth provider for India. | W20 | 57 | +10% | +14% | 0 | $125K | YC investment$125K, Aug 2021 |
We treat women with Polycystic Ovary Syndrome in India | W21 | 48 | −2% | 0 | $3.1M | Seed$3M, Jul 2021 | |
Government-funded online addiction treatment | W21 | 45 | +18% | +41% | 7 | SeedMar 2021 | |
Function Health for Europe | X25 | 44 | +26% | +100% | 3 | $28.5M | Series A$20M, May 2026 |
Autonomous medical care | S21 | 40 | +18% | +60% | 15 | $7.6M | Seed$5.6M, Jan 2026 |
Making mental health accessible to everyone. | W22 | 39 | +5% | +15% | 0 | $3M | YC investment$500K, Mar 2022 |
Disrupting Indian Insurance space by empowering distrubutors | W22 | 32 | +3% | +14% | YC | ||
The #1 App to Quit Porn: Rebuild Focus and Intimacy | S22 | 31 | +3% | 0 | SeedSep 2022 | ||
Digitizing dentistry in LatAm | W20 | 31 | −11% | −26% | 0 | $9.5M | Series A$7M, Oct 2023 |
Affordable mental self-care for all. Acquired by Headspace Health. | W20Acquired | 31 | +7% | +11% | 0 | SeedMar 2020 | |
Rare Disease-Focused Care Delivery and Evidence Generation Platform | S15 | 31 | +7% | 0 | $120K | YC investment$120K, Aug 2015 | |
Automated Meal Planner & Nutrition Tracking | S21 | 27 | −4% | 0 | $125K | YC investment$125K, Aug 2021 | |
Validated mental health support in your pocket, anytime. | W24 | 26 | +30% | +53% | YC | SeedMar 2024 | |
Subscription pharmacy for patients with chronic diseases | S19 | 25 | 0 | $5.7M | Seed$5.5M, Sep 2019 | ||
Digital program for tinnitus | W22 | 24 | +4% | +20% | 0 | $4M | Seed$3.3M, Jul 2022 |
Your voice. Your health. We care. | S17 | 22 | −42% | −45% | 0 | $5.3M | Seed$5.2M, Oct 2017 |
We make it easy to get great ObGyn care in-person and over telehealth | S22Inactive | 19 | −5% | −27% | 0 | $7.5M | Seed$7M, Nov 2022 |
AI-generated personalized nutrition solutions, built for you daily. | S18 | 19 | −10% | −5% | 0 | $14.5M | Series A$10M, Oct 2021 |
23andMe for environmental exposures | S19 | 18 | −14% | −14% | 0 | $436K | Equity crowdfunding$286K, Jan 2022 |
At-cost preventive health: Labs, Scans, Genetics, Supplements and Rx | S24 | 16 | 0% | +14% | 0 | $4M | Seed$2.2M, Mar 2025 |
Search engine for trustworthy medical information. | S23 | 16 | +14% | +23% | 0 | SeedDec 2024 | |
Patent-pending enzymes to break down common dietary triggers | S21 | 15 | +15% | +36% | 0 | $1.6M | Seed$1.5M, Oct 2021 |
Predicting and preventing heart disease. | S15 | 15 | −6% | −12% | 0 | $15.8M | Series A$11.2M, Aug 2020 |
Digital pharmacy for Latam, that saves you money and time. | S21Inactive | 14 | 0% | 0% | 0 | $2.1M | Convertible note$2M, Dec 2021 |
Telemedicine platform for chronic conditions like obesity | W21 | 14 | −22% | −12% | YC | $3.2M | Seed$3.2M, Mar 2021 |
An effective home-use fertility treatment for natural conception | S20 | 14 | −7% | −12% | 0 | Undisclosed roundAug 2020 | |
Modern egg freezing for half the cost in half the time with top docs | W20Inactive | 14 | 0% | +8% | 0 | $2.2M | Seed$1.4M, Apr 2020 |
Democratizing Dermatology with AI | W17 | 13 | +30% | +30% | YC | $10.2M | Undisclosed round$6M, Jun 2022 |
Empowering women. Period. | W16 | 13 | −7% | −13% | 0 | $12.3M | Convertible note$12.3M, Apr 2024 |
Every launched company in YC's public directory, with its batch, status, industry and location. New companies show up the week YC lists them.
Each company is matched to Crustdata by its website. Crustdata adds team size and its change over 6 and 12 months, open roles from job postings, reported funding, and founders' past employers.
Hiring the most counts distinct roles posted in the last 60 days. Growth needs 10+ people today, shrinking 20+ a year ago, so tiny teams do not top the lists. Rebuilt every week.
The numbers on this page come from three Crustdata API calls. Crustdata tags 5,000+ companies with Y Combinator as an investor; swap the filter for any investor, industry or headcount range and track your own list, with founders' work emails one call away.
# 1. every company with Y Combinator as an investor curl https://api.crustdata.com/company/search \ -H "authorization: Bearer $CRUSTDATA_API_KEY" \ -H "x-api-version: 2025-11-01" \ -d '{ "filters": { "field": "funding.investors", "type": "in", "value": ["Y Combinator"] }, "fields": ["basic_info.name", "headcount.total", "headcount.growth_percent", "funding.total_investment_usd"], "limit": 100 }' # 2. open listings per company, last 60 days (limit 0 = counts only) curl https://api.crustdata.com/job/search \ -H "authorization: Bearer $CRUSTDATA_API_KEY" \ -H "x-api-version: 2025-11-01" \ -d '{ "filters": { "op": "and", "conditions": [ { "field": "company.basic_info.company_id", "type": "in", "value": [...] }, { "field": "metadata.date_added", "type": "=>", "value": "2026-08-24" } ]}, "limit": 0, "aggregations": [{ "type": "group_by", "field": "company.basic_info.company_id", "agg": "count" }] }' # 3. the same company filter as a weekly watch: POST /watch/company/search
121 Y Combinator companies are in Consumer Health and Wellness; 83 are active.
12 companies posted roles in the last 60 days, led by Finni Health (83 roles), Legion Health (15 roles) and Mark Cuban Cost Plus Drug Company, PBC (12 roles). 28 mark themselves as hiring on YC's directory.
By team growth over 6 months (10+ people): Clara (+67%), Junction (+37%) and Sonia (+30%).
Largest latest rounds in the last 12 months, after their YC batch: Inito ($29M), Lucis ($20M) and Clara ($12M).